Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies.
Saved in:
| Title: | Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies. |
|---|---|
| Authors: | Arnaud, Laurent1,2,3 Laurent.arnaud@psl.aphp.fr, Mathian, Alexis1,3, Devilliers, Hervé4, Ruffatti, Amelia5, Tektonidou, Maria6, Forastiero, Ricardo7, Pengo, Vittorio8, Lambert, Marc9, Lefevre, Guillaume9, Martinez-Zamora, Maria Angeles10, Balasch, Juan10, Wahl, Denis11, Amoura, Zahir1,3 |
| Source: | Autoimmunity Reviews. Mar2015, Vol. 14 Issue 3, p192-200. 9p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
